Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study aims to determine the efficacy of nebulising 3% hypertonic saline in improving clinical symptoms and reducing the length of hospital stay in infants with acute bronchiolitis.
Epistemonikos ID: 2d3b3490b73541f400fec4d9e71743830939d164
First added on: Sep 01, 2024